American Cancer Society Workshop on Guidelines for Breast Cancer Detection. Chicago, IL, USA, 1997/03/08.
Several recent studies have added significant information regarding the benefit of screening mammography, especially in the 40-49-years age group.
This new information makes it important to reassess the cost-effectiveness of screening.
A Markov model was used to study the cost-effectiveness of 4 age-related screening strategies : 1) annually from ages 40-79 years ; 2) annually from ages 40-64 years and biennially from ages 65-79 years ; 3) annually from ages 40-49 years and biennially from ages 50-79 years ; and 4) annually from ages 40-79 years in high risk women (10%) and biennially from ages 40-49 years followed by annually from ages 50-79 years in normal risk women (90%). An additional strategy simulating hormone status and estrogen exposure was evaluated.
Cost-effectiveness was expressed as marginal cost per year-life saved (MCYLS).
The MCYLS varied from $18,800 to $16,100.
For all strategies this was within the range of other generally acceptable diagnostic and therapeutic medical procedures.
There was a 14% decrease in MCYLS from the least cost-effective to the most cost-effective strategy.
Cost-effectiveness of four age-related mammographic screening strategies was evaluated.
The MCYLS for all strategies was within a generally accepted range.
With increasing concerns regarding the cost of health care, this information may be useful in health policy decision-making.
Mots-clés Pascal : Mammographie, Diagnostic, Dépistage, Analyse coût efficacité, Evaluation performance, Age 40-49, Homme, Femelle, Stratégie, Modèle Markov, Etude statistique, Radiodiagnostic
Mots-clés Pascal anglais : Mammography, Diagnosis, Medical screening, Cost efficiency analysis, Performance evaluation, Age 40-49, Human, Female, Strategy, Markov model, Statistical study, Radiodiagnosis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0296066
Code Inist : 002B20E02. Création : 27/11/1998.